肥胖与女性生殖系统疾病风险:一项孟德尔随机化研究
该研究应用 logistic 回归、广义可加模型和孟德尔随机化(两样本、非线性及多变量)分析英国生物银行中多达 257,193 名欧洲裔女性的肥胖与生殖疾病数据及公开全基因组关联研究数据,发现总体和中心性肥胖指标与子宫肌瘤、多囊卵巢综合征、月经过多和子痫前期风险升高相关,并提示瘦素、空腹胰岛素和胰岛素抵抗可能介导部分关联。
要点
- 观察性与遗传预测的肥胖指标均与子宫肌瘤、多囊卵巢综合征、月经过多和子痫前期风险升高相关。
- 遗传预测内脏脂肪质量每增加 1 kg 与月经过多、多囊卵巢综合征和子痫前期风险升高相关。
- 瘦素、空腹胰岛素和胰岛素抵抗各自介导肥胖与子痫前期遗传预测关联的 20%–50%。
核心结论
- 常见总体和中心性肥胖指标与女性生殖系统疾病风险升高相关,程度不一。
- 结果提示探索超重和肥胖与妇科健康因果关联的中介机制可能有助于确定疾病预防和治疗靶点。
研究设计与样本
- 应用 logistic 回归、广义可加模型和孟德尔随机化(两样本、非线性及多变量)分析英国生物银行中多达 257,193 名欧洲裔女性的肥胖与生殖疾病数据及公开全基因组关联研究数据。
主要发现
- 体质指数、腰臀比和经体质指数调整的腰臀比在观察性分析中与子宫肌瘤、多囊卵巢综合征、月经过多和子痫前期相关(每增加 1 个标准差,比值比[OR]=1.02–1.87),在遗传分析中亦相关(OR=1.06–2.09)。
- 遗传预测内脏脂肪质量每增加 1 kg 与月经过多(OR[95%CI]=1.32[1.06–1.64],P=0.0130)、多囊卵巢综合征(OR[95%CI]=1.15[1.08–1.23],P=3.24×10⁻⁵)和子痫前期(OR[95%CI]=3.08[1.98–4.79],P=6.65×10⁻⁷)发生相关。
- 腰围增加对这些疾病和子宫肌瘤的遗传风险(OR=1.16–1.93)高于臀围增加(OR=1.06–1.10)。
- 瘦素、空腹胰岛素和胰岛素抵抗各自介导肥胖与子痫前期总遗传预测关联的 20%–50%。
- 生殖系统疾病基于其与肥胖病因学关系的共享遗传组分进行聚类。
局限性
- 英国生物银行女性生殖系统疾病患病率低,研究把握度受限。
- 诊断前人体测量特征信息很少。
- 孟德尔随机化估计易受遗传多效性影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Obesity is observationally associated with altered risk of many female reproductive conditions. These include polycystic ovary syndrome (PCOS), abnormal uterine bleeding, endometriosis, infertility, and pregnancy-related disorders. However, the roles and mechanisms of obesity in the aetiology of reproductive disorders remain unclear. Thus, we aimed to estimate observational and genetically predicted causal associations between obesity, metabolic hormones, and female reproductive disorders. METHODS AND FINDINGS: Logistic regression, generalised additive models, and Mendelian randomisation (MR) (2-sample, non-linear, and multivariable) were applied to obesity and reproductive disease data on up to 257,193 women of European ancestry in UK Biobank and publicly available genome-wide association studies (GWASs). Body mass index (BMI), waist-to-hip ratio (WHR), and WHR adjusted for BMI were observationally (odds ratios [ORs] = 1.02-1.87 per 1-SD increase in obesity trait) and genetically (ORs = 1.06-2.09) associated with uterine fibroids (UF), PCOS, heavy menstrual bleeding (HMB), and pre-eclampsia. Genetically predicted visceral adipose tissue (VAT) mass was associated with the development of HMB (OR [95% CI] per 1-kg increase in predicted VAT mass = 1.32 [1.06-1.64], P = 0.0130), PCOS (OR [95% CI] = 1.15 [1.08-1.23], P = 3.24 × 10-05), and pre-eclampsia (OR [95% CI] = 3.08 [1.98-4.79], P = 6.65 × 10-07). Increased waist circumference posed a higher genetic risk (ORs = 1.16-1.93) for the development of these disorders and UF than did increased hip circumference (ORs = 1.06-1.10). Leptin, fasting insulin, and insulin resistance each mediated between 20% and 50% of the total genetically predicted association of obesity with pre-eclampsia. Reproductive conditions clustered based on shared genetic components of their aetiological relationships with obesity. This study was limited in power by the low prevalence of female reproductive conditions among women in the UK Biobank, with little information on pre-diagnostic anthropometric traits, and by the susceptibility of MR estimates to genetic pleiotropy. CONCLUSIONS: We found that common indices of overall and central obesity were associated with increased risks of reproductive disorders to heterogenous extents in a systematic, large-scale genetics-based analysis of the aetiological relationships between obesity and female reproductive conditions. Our results suggest the utility of exploring the mechanisms mediating the causal associations of overweight and obesity with gynaecological health to identify targets for disease prevention and treatment.
引用
- Venkatesh SS, Ferreira T, Benonisdottir S, et al. Obesity and risk of female reproductive conditions: A Mendelian randomisation study. PLoS Med. 2022. PMID: 35104295. doi:10.1371/journal.pmed.1003679
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。